Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC chain drug marketing investigation

Executive Summary

Federal Trade Commission "commenced an investigation" of Rite Aid Sept. 11 on "matters relating to consumer privacy and advertising," the chain drug store says in Oct. 15 10-Q filing with the Securities & Exchange Commission. Walgreens said it has received a letter from FTC requesting information on patient privacy and marketing programs. The Florida Attorney General is also investigating pharmacies' drug marketing practices (1"The Pink Sheet" July 22, p. 27)...

You may also be interested in...



Rx Marketing: Florida Subpoenas Manufacturer Agreements With Pharmacies

The Florida Attorney General has subpoenaed a number of pharmaceutical manufacturers for documents related to marketing agreements with pharmacies

Who’s Hired? Hikma Recruits New US Generics President

A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.

Organon And Henlius Complete Phase III For Denosumab

Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel